The earliest known use of surgical sutures dates back to 3000 BC in ancient Egypt. Since then humans have experimented with sutures made from flax, cotton, hair, tendons, silk and anything vaguely thread-like. Taking surgical suturing to the next level is Orthocell (ASX: OCC), a Western Australian based company developing next-gen regenerative medicine products. The
Read More
Labourers and athletes prone to shoulder injuries could have a significant solution after 89% of patients participating in Orthocell’s (ASX: OCC) tendon regeneration clinical trials, reported a pain-free return to work and recreation. The remaining 11% reported improved mobility and notably, none of the trial participants require further surgery two years on from the initial
Read More